statut,statut_label,statut_name,NCTId,eudraCT,CTIS,completion_year,clinical_trial_title,acronym,results_1y,results_3y,results,intervention_type
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT00291369,,,2005,"PERCY QUATTRO: Medroxyprogesterone, Interferon Alpha-2a, Interleukin 2 or Combination of Both Cytokines in Patients With Metastatic Renal Carcinoma of Intermediate Prognosis",,False,False,False,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT00409071,,,2008,Placebo-controlled Evaluation of Homeopathic Remedy (Cocculine¬Æ) Efficacy in the Management of Nausea After Adjuvant Chemotherapy in Non Metastatic Breast Cancer.,,False,False,True,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01070537,,,2009,INVIBO: Evaluation of the Feasibility and Tolerance of an Intubation Procedure Performed by Means of the Bonfils Fiberscope in Awake Patients With Predicted Difficult Intubation in the Context of ENT Cancer Surgery,INVIBO,False,False,True,DEVICE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT00794261,,,2010,"Assessment of the Efficacy and Tolerance, and Health Economic Study of a Single Administration of Pegfilgrastim in Lymphoma or Myeloma Patients Treated With Intensive Chemotherapy and Autologous Peripheral Stem Cell Transplantation",PALM,False,False,False,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT00973882,,,2010,Phase II Multicenter Study Evaluating the Efficacy of Carboplatin-Etoposide Combination in Hormone-resistant Prostate Cancers With Neuroendocrine Differentiation.,,False,False,True,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT00636467,,,2011,Evaluation of the Technique of Axillary Sentinel Lymph Node (SLN) Detection in Breast Cancers > 2 cm,GAS2PLUS,False,False,True,OTHER
üü•,rouge,r√©sultat post√©s ou publi√©s,,2009-011280-37,,2012,"Efficacy and safety assessment of oral LBH589 in adult patients with advanced soft tissue sarcoma after doxorubicin failure: an open-label, multi-centric phase II study",ESTIM,False,False,True,
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT00619268,,,2012,"Open Label, Randomized, Multicenter Phase II Study of a Combination of Torisel¬Æ (Temsirolimus) and Avastin¬Æ (Bevacizumab) Versus Sutent¬Æ (Sunitinib) and Versus a Combination of Avastin¬Æ (Bevacizumab) and Rof√©ron¬Æ (Interferon Alpha-2a) in First-line Treatment of Patients With Metastatic Renal Cell Carcinoma.",TORAVA,False,False,True,DRUG
üü©,vert,r√©sultat post√©s ou publi√©s dans les 12 mois,NCT01136499,,,2013,"Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft Tissue Sarcoma After Pre-treatment Failure: an Open-label, Multicenter Phase II Study",ESTIM-LBH,True,True,True,DRUG
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT01202032,,,2013,Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors,PARASOL,False,True,True,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01261429,2010-018869-29,,2013,Phase II Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT),PVNS,False,False,True,DRUG
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT00367861,,,2013,A Prospective Multicentric Randomized Study of Glivec¬Æ in Patients With Advanced Gastrointestinal Stromal Tumors Expressing C-kit Comparing Treatment Interruption After 5 Years vs Treatment Maintenance,,False,True,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT00905281,,,2014,"Randomized Controlled Trial Assessing the Impact of Routine ""Oncologist-supportive Care Team"" Consultation on the Use of an Additional Line of Chemotherapy in Metastatic Breast Cancer Patients",,False,False,False,OTHER
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01331772,,,2014,Randomized Controlled Study Assessing the Feasibility and the Medico-economic Impact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy,PASAPAS,False,False,True,OTHER
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01368107,,,2014,"A Randomised, Multicentric, Phase 2a Study Evaluating the Impact of an Immunotherapy by IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients",,False,False,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT01696630,,,2014,"Phase II Study, Randomized, Monocentric, Single-blind, Comparing the Efficacy of Xenon and Desflurane, in Association With a Thoracic Epidural Analgesia in the Maintenance Phase of a Colorectal Oncologic Surgery",,False,False,False,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT00349102,,,2014,Evaluation of the Interest of Breath Holding for the Prevention of Radiation Pneumonitis Following Conformal Radiation Therapy,,False,False,True,RADIATION
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01314300,2010-023461-22,,2014,"VERSATIS - Efficacy and Safety of Lidocaine 5% Plasters (Versatis¬Æ 5%) in Child, Adolescents and Young Adults With Neuropathic Pains or Vasoocclusive Sickle Cell Crisis Pains",VERSATIS,False,False,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT01405430,,,2014,"Exploration of New Biologic Factors' Predictive Value , Especially Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab",AVECC,False,False,False,BIOLOGICAL
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01246427,2009-009867-70,,2014,Placebo-controlled Evaluation of the Homeopathic Drug BRN01 for the Treatment of Hot Flashes in Women With Non Metastatic Breast Cancer Treated by Adjuvant Hormonal Therapy,HBC,False,False,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT01194843,,,2015,A Double-blind Placebo-controlled Evaluation of Ropivacaine Efficacy by Local Per and Post Hepatectomy Infiltrations for Adult Pain Management,DPO,False,False,False,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01738217,,,2015,"Evaluation, for Patients Requiring a Liver Cancer Surgery, of the Use of Fluorescence Imaging Device: Faisability and Efficiency of Lesional and/or Anatomical Marking",HEPATOFLUO,False,False,True,PROCEDURE
üü©,vert,r√©sultat post√©s ou publi√©s dans les 12 mois,NCT01323400,,,2016,"A Phase II Randomized Multicentre Study Evaluating the Efficacy of Pazopanib+Best Supportive Care (BSC) Versus BSC Alone in Metastatic and/or Locally Advanced Unresectable GIST, Resistant to Imatinib and Sunitinib",PAZOGIST,True,True,True,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01308034,,,2016,Phase I Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy,,False,False,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT01460186,,,2017,Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer : a Multicenter Non-randomized Prospective Cohort Study,StoRM,False,False,False,OTHER
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT00978471,2009-009899-12,,2018,Efficacy and Tolerance Adjuvant High-Dose Thiotepa With Peripheral Stem Cell Rescue Associated With Conventional Chemotherapy in Children and Adults With Relapsed Osteosarcoma,OSII-TTP,False,True,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03418597,,,2018,"Randomized, Monocentric, Controlled, Superiority Phase II Trial Evaluating Clinical Hypnosis Using Virtural Reality vs Standard Pain Management Procedure During a Musculoskelettal Biopsy",REVENRI,False,False,False,PROCEDURE
üü©,vert,r√©sultat post√©s ou publi√©s dans les 12 mois,NCT03148886,,,2018,Advanced Breast Cancer and Lifestyle Exercise Study,ABLE,True,True,True,OTHER
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT01813136,2012-003162-41,,2019,"A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma","PAZOTHYR 
 
 
 PAZOTHYR",False,True,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02489695,,,2019,Multicenter Phase II Study of Axitinib in First Line Treatment for Patients With Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC),AXIPAP,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03330730,,,2019,"A Randomized, Controlled, Multicenter, Prospective, Open Study Evaluating the Efficiency of the IsereADOM Home-care Service Package in the Prevention of Unplanned Hospitalizations of Patients With Cancer",IsereADOM,False,False,False,OTHER
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03336905,,,2019,Implementation of a Program Based on Adapted Physical Activity and Recommendations for Second Cancers Prevention for Teenagers and Young Adults With Cancer,PREVAPAJA,False,False,False,OTHER
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT03139851,2016-002736-33,,2019,CHEMOIMMUNE - A Phase II Study Evaluating an Anti-PD1 Monoclonal Antibody (Pembrolizumab) in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide,CHEMOIMMUNE,False,True,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02777710,,,2019,A Dose Escalation Phase I Study With an Extension Part Evaluating the Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With a Small Molecule CSF-1R Tyrosine Kinase Inhibitor (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers,MEDIPLEX,False,False,False,DRUG
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT01737450,2012-002403-18,,2019,"A Phase II, Multicenter Trial Aiming to Evaluate the Clinical Interest of a Monotherapy With BKM120 , a Phosphoinositide 3-kinase (PI3K) Inhibitor in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive Under Platin and Cetuximab-based Chemotherapy",PIK-ORL,False,True,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT01635270,,,2020,Randomized Phase 2 Study Evaluating the Interest of Mid-position Strategy Versus ITV (Internal Target Volume) Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-resected Non-small Cell Lung Carcinoma (NSCLC).,midP,False,False,False,RADIATION
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02576106,,,2020,Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy,CRYOSE01,False,False,False,DEVICE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03421912,,,2021,"Comparative Monocentric Randomized Study Evaluating the Satisfaction and Quality of Life of Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGRF) in Carcinomas Squamous Cells of the Head and Neck, Colorectal Cancers or Lung Cancers",CICAFIX,False,False,False,OTHER
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,,2019-001711-23,,2021,"CICA-RT ‚Äì Phase III randomized multicenter study evaluating Cicaderma¬Æ ointment efficacy versus the current practice of each center for the radiation dermatitis prevention in patients with non-metastatic breast cancer after adjuvant post-operative breast irradiation  
 
 
 CICA-RT ‚Äì Etude multicentrique randomis√©e de phase III √©valuant l‚Äôefficacit√© de la pommade Cicaderma¬Æ versus la pratique courante de chaque centre sur la pr√©vention des radiodermites apr√®s prise en charge adjuvante par irradiation mammaire post-op√©ratoire chez des patientes atteintes d‚Äôun cancer du sein non m√©tastatique","CICA-RT 
 
 
 CICA-RT",False,True,True,
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT04510454,,,2021,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,ONCOVID-21,False,False,False,DIAGNOSTIC_TEST
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02013297,,,2021,"Hypofractionated Stereotactic Radiation Treatments (SBRT) on Children, Teenagers and Young Adults Malignant Tumors",SBRT,False,False,False,RADIATION
üüß,orange,r√©sultat post√©s ou publi√©s dans les 36 mois,NCT01427478,2010-023265-22,,2021,"A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy of Afatinib (BIBW2992) in Maintenance Therapy After Post- Operative Radio-chemotherapy in Squamous-cell Carcinoma of the Head and Neck: GORTEC 2010-02",BIBW2992ORL,False,True,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT04333914,,,2021,"A Prospective, Controlled, Randomized, Multicenter Study of the Efficacy of an Autophagy Inhibitor (GNS561), an Anti-NKG2A (Monalizumab) and an Anti-C5aR (Avdoralimab) Compared to the Standard of Care in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection.",IMMUNONCOVID,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03163732,,,2021,"A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (Panel FoundationOne) Versus a Limited Molecular Profiling Panel (Panel CONTROL) in Advanced Solid Tumors.",PROFILER 02,False,False,False,GENETIC
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02104986,,,2021,A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent,,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02977156,,,2022,A Phase I Dose Escalation Trial Evaluating the Impact of an in Situ Immunization Strategy With Intra-Tumoral Injections of Pexa-Vec in Combination With Ipilimumab in Metastatic / Advanced Solid Tumors With Injectable Lesions.,ISI-JX,False,False,False,BIOLOGICAL
üü©,vert,r√©sultat post√©s ou publi√©s dans les 12 mois,NCT03529383,,,2022,Randomized Controlled Trial Evaluating the Efficacy of an Adapted Physical Activity Program Using a Connected Device With Activity Trackers and a Therapeutic Education Program Among Women With Localized Breast Cancer,DISCO,True,True,True,BEHAVIORAL
üü©,vert,r√©sultat post√©s ou publi√©s dans les 12 mois,NCT03871959,,,2022,CATRIPCA - A Phase I Study of PD1 Monoclonal Antibody (Pembrolizumab) In Combination With a IAP Antagonist (Debio 1143) In (Exocrine) Pancreatic And Colorectal Non MSI-high Advanced/Metastatic Adenocarcinoma.,CATRIPCA,True,True,True,DRUG
üü©,vert,r√©sultat post√©s ou publi√©s dans les 12 mois,NCT02977195,,,2022,"NP137 - An Open-label, First in Human, Phase I Trial Aiming to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of a Humanized Monoclonal Antibody Targeting Netrin 1 (NP137) in Patients With Advanced/Metastatic Solid Tumors.",NP137,True,True,True,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03356223,,,2022,"A Phase II Trial Aiming to Evaluate the Clinical Interest of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6",ABORL,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03721120,,,2023,A Randomized Phase III Clinical Trial to Evaluate the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer,LIBELULE,False,False,False,DIAGNOSTIC_TEST
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03714958,,,2023,"A Single-center, Phase 1 Dose Escalation Study of Trametinib Combined With HDM201 in Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer.",TRAHD,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT02260505,,,2023,A Randomized Multicenter Phase III Trial Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST),ImadGist,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT05568667,,,2023,"Pilot Study to Improve Primary Prevention of Colorectal Cancer by Motivational and Community-based Approaches, According to Individual Risk Level, in People Undergoing Colonoscopy",,False,False,False,BEHAVIORAL
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT05273931,,,2023,Evaluation of a Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN Pilot),,False,False,False,OTHER
üü©,vert,r√©sultat post√©s ou publi√©s dans les 12 mois,NCT04052126,,,2023,An Interventional Prospective Study to Test the Feasibility of an Individualized Physical Activity Program in Patients Over 65 Years of Age With Hematologic Malignancies: the OCAPI Project.,OCAPI,True,True,True,OTHER
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT05881148,,,2023,"Carbon "" Super Spikes "" Performances on Sprint Acceleration : Just Use it? A Multiple N-of-1 Trial. A Multiple N-of-1 Trial in Healthy Athletes",CS3T,False,False,False,OTHER
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03967522,,2024-512630-15-00,2024,CABRAMET: A Phase 2 Study of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases,CABRAMET,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT04193553,,2024-513984-22-00,2024,"A Multicentre, Comparative, Placebo-controlled, Double-blinded, Phase II Study of the Efficacy of Lenvatinib in Patients With Locally Advanced or Metastatic GIST After Failure of Imatinib and Sunitinib",LENVAGIST,False,False,False,DRUG
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT05298930,,,2024,"A Feasibility Study Evaluating Connected Bikes as a Means of Adapted Physical Activity in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation",EVAADE,False,False,False,OTHER
üü©,vert,r√©sultat post√©s ou publi√©s dans les 12 mois,NCT04676009,,,2024,Feasibility of an Acute Physical Exercise Before Immunotherapy and Chemotherapy Infusion for Metastatic Non-small-cell Lung Cancer Patients: Protocol ERICA Study,ERICA,True,True,True,OTHER
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT05944900,,,2024,"Randomized, Prospective, Single-center Trial Comparing the Efficacy of Peripherally Inserted Central Catheter (PICC) Placement With the Addition of Cyanoacrylate Glue Versus PICC Placement Alone (Without Glue) in Patients With Cancer.",PICCandGLUE,False,False,False,PROCEDURE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,,2018-000414-38,,2024,"Frail-Immune (GORTEC-2018-03) - A multicenter, prospective, single arm phase II study evaluating the efficacy and safety of the combination of Durvalumab with carboplatin and paclitaxel as first line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck not eligible to standard chemotherapy 
 
 
 Frail-Immune (GORTEC-2018-03) - Etude de phase II, monobras, prospective, multicentrique √©valuant l‚Äôefficacit√© et la tol√©rance de l‚Äôassociation du Durvalumab avec la Carboplatine et le Paclitaxel, en traitement de premi√®re ligne chez des patients porteurs d‚Äôun carcinome   √©pidermo√Øde de la t√™te et du cou r√©current / m√©tastatique non √©ligibles √† la chimioth√©rapie standard","Frail-Immune 
 
 
 Frail-Immune",False,False,False,
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT03723967,,,2024,Multicenter Prospective Single Arm Phase II Study Evaluating Efficacy & Safety of Durvalumab With Carboplatin/Paclitaxel as First Line Treatment in Patients With Recurrent/Metastatic SCCHN Not Eligible to Standard Chemotherapy,FRAIL-IMMUNE,False,False,False,DRUG
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT01262417,,,,Evaluationof the Efficiency of a Resorbable Barrier Membrane for the Prevention of Abdominal and Peri-hepatic Adhesion in Patients With Colorectal Cancer Requiring Two-stage Surgery for the Resection of Hepatic Metastases,SEPRAC2T,False,False,True,PROCEDURE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,NCT00820963,,,,Randomized Study of Normal-fractionated Radiotherapy Versus Hypofractionated Radiotherapy Versus Chemotherapy in Patients Over 60 Years With Malignant Glioma,,False,False,False,RADIATION
üü•,rouge,r√©sultat post√©s ou publi√©s,NCT00775112,,,,Randomized Evaluation of a Positioning Pillow for Lumbar Puncture in Paediatric Hematology-Oncology,,False,False,True,DEVICE
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,,2016-004537-25,,,"An Phase II trial aiming to evaluate the clinical interest of ABEMACICLIB monotherapy in patients with locally advanced/metastatic head and neck cancer after failure of platinum and cetuximab or anti-EGFR-based therapy and harboring an homozygous deletion of CDKN2A, and/or an amplification of CCND1 and/or of CDK6 
 
 
 AB-ORL - Etude de Phase II visant √† √©valuer l‚Äôint√©r√™t clinique d‚Äôune monoth√©rapie par abemaciclib chez des patients atteints d‚Äôun cancer de la t√™te et du cou localement avanc√© ou m√©tastatique apr√®s √©chec d‚Äôune th√©rapie √† base de platine et de cetuximab ou anti-EGFR, et pr√©sentant une d√©l√©tion homozygote du g√®ne CDKN2A, et/ou une amplification du g√®ne CCND1 et/ou du g√®ne CDK6.","ABORL 
 
 
 ABORL",False,False,False,
‚¨õ,noir,pas de r√©sultat post√©s ni publi√©s,,2017-003151-34,,,"A multicenter, randomised, open-label Phase II study to evaluate the clinical benefit of a post-operative treatment associating radiotherapy + Nivolumab + Ipilimumab versus radiotherapy + Capecitabine for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy. 
 
 
 Etude multicentrique de Phase II, randomis√©e, men√©e en ouvert visant √† √©valuer le b√©n√©fice clinique d‚Äôun traitement post-op√©ratoire associant radioth√©rapie + Nivolumab + Ipilimumab versus radioth√©rapie + Cap√©citabine chez des patientes atteintes d‚Äôun cancer du sein triple n√©gatif et pr√©sentant une maladie r√©siduelle apr√®s chimioth√©rapie n√©oadjuvante.",BreastImmune03,False,False,False,
